Premium
Rifaximin reduces endotoxemia and improves liver function and disease severity in patients with decompensated cirrhosis
Author(s) -
Kalambokis Georgios N.,
Tsianos Epameidas V.
Publication year - 2012
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.24751
Subject(s) - cirrhosis , medicine , gastroenterology , rifaximin , hepatic encephalopathy , liver function , ascites , liver disease , neomycin , spontaneous bacterial peritonitis , hepatology , albumin , antibiotics , biology , microbiology and biotechnology
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom